title: Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via upregulation of SOCS1 and SOCS3.
abstract: Highly pathogenic avian influenza virus infection is associated with severe mortality in both humans and poultry. The mechanisms of disease pathogenesis and immunity are poorly understood although recent evidence suggests that cytokine/chemokine dysregulation contributes to disease severity following H5N1 infection. Influenza A virus infection causes a rapid influx of inflammatory cells, resulting in increased reactive oxygen species production, cytokine expression, and acute lung injury. Proinflammatory stimuli are known to induce intracellular reactive oxygen species by activating NADPH oxidase activity. We therefore hypothesized that inhibition of this activity would restore host cytokine homeostasis following avian influenza virus infection. A panel of airway epithelial and immune cells from mammalian and avian species were infected with A/Puerto Rico/8/1934 H1N1 virus, low-pathogenicity avian influenza H5N3 virus (A/duck/Victoria/0305-2/2012), highly pathogenic avian influenza H5N1 virus (A/chicken/Vietnam/0008/2004), or low-pathogenicity avian influenza H7N9 virus (A/Anhui/1/2013). Quantitative real-time reverse transcriptase PCR showed that H5N1 and H7N9 viruses significantly stimulated cytokine (interleukin-6, beta interferon, CXCL10, and CCL5) production. Among the influenza-induced cytokines, CCL5 was identified as a potential marker for overactive immunity. Apocynin, a Nox2 inhibitor, inhibited influenza-induced cytokines and reactive oxygen species production, although viral replication was not significantly altered in vitro. Interestingly, apocynin treatment significantly increased influenza virus-induced mRNA and protein expression of SOCS1 and SOCS3, enhancing negative regulation of cytokine signaling. These findings suggest that apocynin or its derivatives (targeting host responses) could be used in combination with antiviral strategies (targeting viruses) as therapeutic agents to ameliorate disease severity in susceptible species.
  
  
  OBJECTIVE
  Highly pathogenic avian influenza virus infection causes severe morbidity and mortality in both humans and poultry. Wide-spread antiviral resistance necessitates the need for the development of additional novel therapeutic measures to modulate overactive host immune responses after infection. Disease severity following avian influenza virus infection can be attributed in part to hyperinduction of inflammatory mediators such as cytokines, chemokines, and reactive oxygen species. Our study shows that highly pathogenic avian influenza H5N1 virus and low-pathogenicity avian influenza H7N9 virus (both associated with human fatalities) promote inactivation of FoxO3 and downregulation of the TAM receptor tyrosine kinase, Tyro3, leading to augmentation of the inflammatory cytokine response. Inhibition of influenza-induced reactive oxygen species with apocynin activated FoxO3 and stimulated SOCS1 and SOCS3 proteins, restoring cytokine homeostasis. We conclude that modulation of host immune responses with antioxidant and/or anti-inflammatory agents in combination with antiviral therapy may have important therapeutic benefits.
authors.affiliation: School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia AAHL CSIRO Deakin Collaborative Biosecurity Laboratory, CSIRO Biosecurity Flagship, Australian Animal Health Laboratory, Geelong, Victoria, Australia siying.ye@deakin.edu.au.
authors.forename: Siying
authors.initials: S
authors.lastname: Ye
authors.affiliation: CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia.
authors.forename: Sue
authors.initials: S
authors.lastname: Lowther
authors.affiliation: School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia AAHL CSIRO Deakin Collaborative Biosecurity Laboratory, CSIRO Biosecurity Flagship, Australian Animal Health Laboratory, Geelong, Victoria, Australia.
authors.forename: John
authors.initials: J
authors.lastname: Stambas
mesh_terms: D000098:Acetophenones / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D002460:Cell Line; D002645:Chickens; D016207:Cytokines / Q000096:biosynthesis; D004372:Ducks; D020869:Gene Expression Profiling; D006801:Humans; D009980:Influenza A virus / Q000276:immunology*; D017382:Reactive Oxygen Species / Q000037:antagonists & inhibitors / Q000633:toxicity*; D060888:Real-Time Polymerase Chain Reaction; D000071222:Suppressor of Cytokine Signaling 1 Protein; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins / Q000378:metabolism*
chemical_list: D000098:Acetophenones; D000975:Antioxidants; D016207:Cytokines; D017382:Reactive Oxygen Species; C108944:SOCS1 protein, human; C106644:SOCS3 protein, human; D000071222:Suppressor of Cytokine Signaling 1 Protein; D000071223:Suppressor of Cytokine Signaling 3 Protein; D050826:Suppressor of Cytokine Signaling Proteins; C056165:acetovanillone